CL2020002908A1 - Nuevo modulador de receptores transmembrana metabotrópico e ionotrópico y sus usos. - Google Patents

Nuevo modulador de receptores transmembrana metabotrópico e ionotrópico y sus usos.

Info

Publication number
CL2020002908A1
CL2020002908A1 CL2020002908A CL2020002908A CL2020002908A1 CL 2020002908 A1 CL2020002908 A1 CL 2020002908A1 CL 2020002908 A CL2020002908 A CL 2020002908A CL 2020002908 A CL2020002908 A CL 2020002908A CL 2020002908 A1 CL2020002908 A1 CL 2020002908A1
Authority
CL
Chile
Prior art keywords
receptor modulator
transmembrane receptor
metabotropic
new
ionotropic
Prior art date
Application number
CL2020002908A
Other languages
English (en)
Inventor
Vladimir Evgenievich Nebolsin
Original Assignee
Ibd Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ibd Therapeutics Llc filed Critical Ibd Therapeutics Llc
Publication of CL2020002908A1 publication Critical patent/CL2020002908A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CL2020002908A 2018-05-11 2020-11-09 Nuevo modulador de receptores transmembrana metabotrópico e ionotrópico y sus usos. CL2020002908A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2018117463A RU2697414C1 (ru) 2018-05-11 2018-05-11 Новый антагонист тахикининовых рецепторов и его применение

Publications (1)

Publication Number Publication Date
CL2020002908A1 true CL2020002908A1 (es) 2021-03-26

Family

ID=67640490

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020002908A CL2020002908A1 (es) 2018-05-11 2020-11-09 Nuevo modulador de receptores transmembrana metabotrópico e ionotrópico y sus usos.

Country Status (19)

Country Link
US (1) US11414377B2 (es)
EP (1) EP3792247A4 (es)
JP (1) JP7301954B2 (es)
KR (1) KR20210008061A (es)
CN (1) CN112384495B (es)
AU (1) AU2019267188B2 (es)
CA (1) CA3099849A1 (es)
CL (1) CL2020002908A1 (es)
CU (1) CU24662B1 (es)
EA (1) EA202092712A1 (es)
GE (1) GEP20237454B (es)
IL (1) IL278603B2 (es)
MA (1) MA52582A (es)
MX (1) MX2020012035A (es)
PH (1) PH12020551928A1 (es)
RU (1) RU2697414C1 (es)
SG (1) SG11202011189TA (es)
WO (1) WO2019216795A1 (es)
ZA (1) ZA202007027B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2697414C1 (ru) * 2018-05-11 2019-08-14 Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" Новый антагонист тахикининовых рецепторов и его применение

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579841A (en) * 1981-07-20 1986-04-01 University Patents, Inc. Dipeptide derivatives having opiate activity
US5610145A (en) * 1994-04-15 1997-03-11 Warner-Lambert Company Tachykinin antagonists
EA002348B1 (ru) * 1995-02-22 2002-04-25 Новартис Аг Соединения 1-арил-2-ациламиноэтана и их применение в качестве антагонистов нейрокинина, в частности нейрокинина 1
MY132550A (en) * 1996-08-22 2007-10-31 Novartis Ag Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
GB9907571D0 (en) 1999-04-06 1999-05-26 Zeneca Ltd Compounds
ES2307605T3 (es) 2000-04-06 2008-12-01 Astrazeneca Ab Nuevos antagonistas de neuroquininas para su uso como medicamentos.
AU2001244999A1 (en) 2000-04-06 2001-10-23 Astrazeneca Ab Naphthamide neurokinin antagonists for use as medicaments
SE0003476D0 (sv) 2000-09-28 2000-09-28 Astrazeneca Ab Compounds
EP1295599A1 (en) 2001-09-21 2003-03-26 Boehringer Ingelheim International GmbH Method for the treatment of prevention of atopic dermatitis
RU2309144C2 (ru) * 2005-03-25 2007-10-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Фенилсодержащие n-ацильные производные аминов, способ их получения, фармацевтическая композиция и их применение в качестве противовоспалительных и анальгетических средств
CN107739316B (zh) * 2017-11-14 2020-07-14 中国医科大学 一种溴代酪氨酸生物碱类化合物及其制备方法和用途
RU2697414C1 (ru) * 2018-05-11 2019-08-14 Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" Новый антагонист тахикининовых рецепторов и его применение

Also Published As

Publication number Publication date
PH12020551928A1 (en) 2021-06-14
IL278603B2 (en) 2024-03-01
CA3099849A1 (en) 2019-11-14
AU2019267188A1 (en) 2020-11-26
ZA202007027B (en) 2022-08-31
US20210070692A1 (en) 2021-03-11
IL278603A (es) 2021-03-01
MX2020012035A (es) 2021-03-29
JP7301954B2 (ja) 2023-07-03
MA52582A (fr) 2021-03-17
CU20200083A7 (es) 2021-06-08
EP3792247A4 (en) 2022-01-12
BR112020022807A2 (pt) 2021-02-02
IL278603B1 (en) 2023-11-01
SG11202011189TA (en) 2020-12-30
RU2697414C1 (ru) 2019-08-14
EA202092712A1 (ru) 2021-02-17
EP3792247A1 (en) 2021-03-17
AU2019267188B2 (en) 2024-02-15
WO2019216795A1 (ru) 2019-11-14
CN112384495B (zh) 2023-07-18
CN112384495A (zh) 2021-02-19
GEP20237454B (en) 2023-01-10
JP2021523235A (ja) 2021-09-02
US11414377B2 (en) 2022-08-16
CU24662B1 (es) 2023-05-11
KR20210008061A (ko) 2021-01-20

Similar Documents

Publication Publication Date Title
DK3490565T3 (da) Azetidinderivater som chemokinreceptormodulatorer og anvendelser deraf
DK3583203T3 (da) Donorreparationstemplates multiplex-genomeditering
MA43382A (fr) Modulateurs des récepteurs des chimiokines
DK3227339T3 (da) Kimæriske antigenreceptorer rettet mod g-protein-koblet receptor og anvendelser deraf
NZ730208A (en) Costimulatory chimeric antigen receptor t cells targeting il13rα2
DK3126380T3 (da) Kimærisk antigen receptor-signalsystem (car)
DK3322701T3 (da) Ethynylderivater som metabotropiske glutamatreceptormodulatorer
DK3490986T3 (da) Piperidin-cxcr7-receptormodulatorer
DK3160964T3 (da) Arylreceptormodulatorer og fremgangsmåder til fremstilling og brug af samme
MA53124A (fr) Agents de dégradation sélectifs des récepteurs des oestrogènes
DK3319963T3 (da) Substituerede 4-azaindoler og deres anvendelse som glun2b receptormodulatorer
DK3523315T3 (da) Inhibitor af glucocorticoidreceptor
DK3676561T3 (da) Systemer og fremgangsmåder til påføring af markeringer
DK3625228T3 (da) Pyrimidinderivater som pge2-receptormodulatorer
MA52555A (fr) Modulateurs du récepteur des oestrogènes
ECSP21001786A (es) Degradadores selectivos del receptor de estrógeno
DK3548383T3 (da) System og fremgangsmåde til fortøjning af et luftskib, dermed udstyret luftskib og dermed udstyrede modtagestrukturer
DK3386591T3 (da) Heteroaromatic nmda receptor modulators and uses thereof
DK3651913T3 (da) Dyseapparat til dispensering af farvestof
DK3145916T3 (da) Imidazolderivater som formylpeptidreceptormodulatorer
FR3022684B1 (fr) Dispositif a membrane a germanium sous contrainte
CL2020002908A1 (es) Nuevo modulador de receptores transmembrana metabotrópico e ionotrópico y sus usos.
ITUA20163193A1 (it) Copolimeri biodegradabili ad uso cosmetico.
DK3700922T3 (da) Vesikel, hvori der indgår transmembranprotein
DK3527477T3 (da) Fartøj til bugsering af et andet fartøj